Exane Derivatives Adma Biologics, Inc. Transaction History

Exane Derivatives

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$1.43 - $2.2 $1,857 - $2,857	-1,299 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$1.28 - $1.83 $34,622 - $49,499	-27,049 Reduced 95.42%	1,299 $2,000
Q4 2021 Jan 28, 2022	BUY	$1.09 - $1.66 $30,899 - $47,057	28,348 New	28,348 $39,000
Q1 2021 Apr 30, 2021	SELL	$1.67 - $2.95 $2,533 - $4,475	-1,517 Closed	0 $0
Q3 2020 Oct 06, 2020	SELL	$2.04 - $3.74 $55,153 - $101,114	-27,036 Reduced 94.69%	1,517 $3,000
Q2 2020 Jul 10, 2020	BUY	$2.42 - $3.29 $69,098 - $93,939	28,553 New	28,553 $83,000

318

184M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.62B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.